Lions Health preview: 2019 attendees scouting for edgy tech, new ideas and a little respect

Cannes Lions Health kicks off its sixth year Monday, and this year’s attendees are looking for some breakouts. As in breakthrough technology, creativity that breaks barriers, groundbreaking global ideas and a chance to finally break with the backhanded compliment that Lions Health work is “good for pharma.” The creative celebration of pharma and healthcare advertising… Read More »

Bluebird CEO defends $1.8 million gene therapy price — ‘It’s really thinking about it differently’

Bluebird Bio CEO Nick Leschly on Friday defended the biotech company’s $ 1.8 million price tag for its new gene therapy to treat a rare genetic blood disorder. Bluebird’s therapy, Zynteglo, was approved in Europe earlier this month for patients with beta thalassemia who require regular blood transfusions to manage their disease and have no… Read More »